CELU
Celularity Inc
NASDAQ: CELU · HEALTHCARE · BIOTECHNOLOGY
$0.93
-2.68% today
Updated 2026-04-30
Market cap
$32.01M
P/E ratio
—
P/S ratio
0.79x
EPS (TTM)
$-3.33
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Celularity Inc (CELU) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.93
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$9.22
Financial forecast
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -198.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.